Accumulation of prelamin A compromises NF-κB-regulated B-lymphopoiesis in a progeria mouse model by Baohua Liu et al.
Liu et al. Longevity & Healthspan 2013, 2:1
http://www.longevityandhealthspan.com/content/2/1/1RESEARCH Open AccessAccumulation of prelamin A compromises
NF-κB-regulated B-lymphopoiesis in a progeria
mouse model
Baohua Liu1,2, Shuangcheng Zhou1, Xinguang Liu2, Keyuan Zhou2, Fengju Zhang3 and Zhongjun Zhou1*Abstract
Background: Alteration in the immune system is one of the most profound aspects of aging. Progressive changes
in the number of B lymphocyte progenitors during aging have been reported but the underlying mechanisms are
still elusive. A heterozygous G608G mutation in the LMNA gene leads to a deletion of 50 amino acids in lamin A
protein, termed progerin, and is the predominant cause of Hutchinson-Gilford progeria syndrome (HGPS). Lack of
Zmpste24, a metalloproteinase responsible for prelamin A processing, leads to progeroid features resembling HGPS.
Therefore Zmpste24-deficient mice provide an ideal mouse model to study the impact of lamin A and (premature)
aging on the aging-related decline of B lymphopoiesis.
Results: Analysis of bone marrow (BM) nucleated cells revealed a decline of early B cell progenitors in Zmpste24−/−
mice. BM transplantation in a congenic strain completely rescued the defects in B lymphopoiesis, indicating that
the decline in B cell progenitors in Zmpste24−/− mice is attributable to defective BM microenvironments rather than
to cell-intrinsic defects. Further investigation revealed downregulation of a set of important early B lymphopoiesis
factors in Zmpste24−/− bone marrow stromal cells (BMSCs), such as Vcam-1, SDF-1α, Flt3L and TSLP, and most of
them are under transcriptional control of NF-κB signaling. Though TNFα stimulates IκBα degradation and NF-κB
nuclear translocation in Zmpste24−/− BMSCs, NF-κB fails to stimulate IκBα re-expression, which mediates a negative
feedback loop of NF-κB signaling in wild-type BMSCs.
Conclusions: Our data demonstrate a cell-extrinsic defect of B cell development in a progeroid mouse model and
a critical role for lamin A in the regulation of NF-κB signaling and cytokines that are essential for lymphopoiesis.
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Aging is a progressive deterioration of physiological
functions that are necessary for survival and fertility [1].
Alteration in the immune system is one of the most pro-
found aspects of aging, including shrinkage of the diverse
repertoire of immunoglobins in both B and T lymphocytes
[2,3], compromised immune responsiveness to pathogens,
which is marked by greater proportion of low-affinity anti-
bodies and involves both humoral and cell-mediated
immune response [4,5], and increased auto-reactive cells
leading to higher risk of autoimmune diseases [6].* Correspondence: zhongjun@hku.hk
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reproduction in any medium, provided the orB lymphocytes are one of the main components of the
adaptive immune system and are responsible for the
generation of B cell receptors (BCRs, also known as
immunoglobulins), which recognize a large repertoire of
antigens [7]. The B cell development is a highly ordered
process orchestrated by differentiation from hematopoietic
stem cells (HSCs). The initial commitment to the B cell
lineage is characterized by the expression of CD45R/B220,
leading to the earliest fraction of B cell progenitors, precur-
sor of B cell progenitor (pre-pro-B) [8,9]. Pre-pro-B cells
give rise to progenitor B (pro-B) cells [10,11]. The following
stage is B cell precursors (pre-B), comprising mainly small
resting cells. The subsequent expression of surface im-
munoglobulin M (sIgM) is the hallmark of the progression
from pre-B cells to immature B cells when they start to
leave bone marrow (BM) niches and enter the peripheralThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Liu et al. Longevity & Healthspan 2013, 2:1 Page 2 of 9
http://www.longevityandhealthspan.com/content/2/1/1blood for further maturation. Contrasting to myeloid
compartments, which are relatively intact during aging, B
lymphopoiesis declines significantly with age [12].
However, the underlying mechanisms remain elusive.
Hutchinson-Gilford progeria syndrome (HGPS) is an
extremely rare genetic disorder of early onset premature
aging. Patients with HGPS can only live for 12 to 16
years and are clinically characterized with early growth
retardation, small body size, lipodystrophy, loss of hair, stiff
joints, reduced bone density, dilated cardiomyopathy and
atherosclerosis [13,14]. HGPS is predominantly caused by a
de novo p.G608G lamin A mutation. Lamin A is first
synthesized as prelamin A with an additional 18 amino
acids on the C-terminus, which dictates a series of proces-
sing events involving farnesylation, proteolysis and methyla-
tion [15-17]. ZMPSTE24, a metalloprotease, is required for
the proteolytic cleavages during lamin A maturation [18].
The G608G mutation activates a cryptic splicing donor
signal in exon 11, leading to a 150-nucleotide deletion in
the LMNA transcript and a 50-residue truncation in the
prelamin A protein, referred to as progerin. Progerin lacks
the second proteolytic cleavage site of ZMPSTE24 but
retains the CAAX motif [19,20]. Mice lacking Lmna surfer
from growth retardation and muscle dystrophy, resembling
Emery-Dreifuss muscular dystrophy (EDMD) [21]; deplet-
ing Zmpste24 in mice recapitulates many progeroid fea-
tures found in HGPS patients [16]. Lmna−/−Zmpste24−/−
double knockout mice phenotypically resemble Lmna
single knockouts, while depleting only one allele of Lmna
ameliorates progeroid phenotypes and extends lifespan in
Zmpste24−/− mice [22,23]. This suggests that prelamin
A is most likely the only substrate of Zmpste24, and
unprocessed prelamin A is the direct cause of premature
aging imposed by Zmpste24 deficiency.
Alternate splicing also happens at the wild type LMNA
locus, leading to expression of low levels of progerin [24]
and indicating that HGPS might share, at least partially,
mechanism(s) with normal aging process. This idea is sup-
ported because the expression of ectopic progerin results
in defective proliferation and premature senescence in
human cells [25,26]; the number of progerin positive cells
gradually increase during aging in normal individuals [27];
and telomere shortening or dysfunction activates progerin
production [28]. Therefore Zmpste24-deficient mice pro-
vide an ideal mouse model to study the impact of lamin A
and (premature) aging on the decline of B lymphopoiesis.
It has been recently reported that loss of Lmna in mice
causes non-cell autonomous defects of B cell development,
possibly attributable to compromised bone marrow
stromal cells (BMSCs) and/or the overall unhealthiness of
the mutants [29]. In the current study, we asked whether
the accumulation of prelamin A affects B lymphopoiesis in
Zmpste24−/− mice. We found an extrinsic decline of early
B lymphocyte progenitors in Zmpste24−/− mice. Defects inearly B lymphopoiesis are most likely attributable to de-
fective BM niches as in vitro cultured Zmpste24−/− BMSCs
are compromised in NF-κB signaling and the secretion of
cytokines necessary for early B lymphopoiesis, including
Vcam-1, SDF-1α, Flt3L, TSLP, etcetera. Our data reveal a
critical role for lamin A in regulating NF-κB signaling that
is essential for lymphopoiesis.
Results
Defective B lymphopoiesis in Zmpste24−/− mice
We first examined whether there is any difference in the B
cell development in Zmpste24−/− mice. As shown in
Figure 1A, the number of nucleated BM cells from femurs
and tibias decreased in Zmpste24−/− mice when comparing
with Zmpste24+/− mice, which are phenotypically indistin-
guishable from their Zmpste24+/+ littermates. Of note,
while the number of nucleated BM cells increased along
with age in Zmpste24+/− mice, no further increase was
observed after 3 months of age in Zmpste24−/− mice. We
then performed FACS analysis on Zmpste24−/− mice at 1
month, 3 months and 5 months of age using their
sex-matched heterozygous littermates as controls.
While 1-month-old Zmpste24−/− mice had a similar
profile of early B cells to that of their heterozygous
littermates, Zmpste24−/− mice of 3 months and 5
months of age showed a significant decrease in the
number of B lymphocytes as well as the percentage
of pro-B (identified as B220loCD43+) and pre-B
(identified as B220loCD43−) populations (Figure 1B-D), sug-
gesting a defect in the generation of B lineage lymphocyte
progenitors, which is consistent with the previous reports
on physiologically senescent mice [30-32].
Defective B lymphopoiesis in Zmpste24−/− mice is not
cell-intrinsic
The defective B lymphopoiesis observed in Zmpste24−/−
mice could be either cell-intrinsic or cell-extrinsic. To
identify this, the BM transplantation test was performed
with congenic strain B6 as recipients. A comparable
number of nucleated BM cells from either 6-month-old
Zmpste24 null mice or their wild-type littermates was
transplanted into lethally irradiated B6 mice and kept
for 2 months before fluorescence-activated cell sorting
(FACS) analysis. The BM cells of donor origin (CD45.2+)
are identified with FITC-CD45.2 antibody. Two months
after the transplantation, FACS analysis showed that
the engraftment efficiency is between 90% and 96%
(Figure 2A). However, the donor-derived cells of
Zmpste24 null mice showed no significant difference in
the profiling of early B cell development, including the
proportions of B lineage progenitors and circulating B
cells when compared with wild-type origin (Figure 2).
These results indicate that the defects observed in early
B cell development in Zmpste24-deficient mice are not
Figure 1 Defective B cell development in Zmpste24−/− mice. (A) Decreased bone marrow nucleated cells in Zmpste24−/− mice compared to
their wild-type littermates. Data represent mean ± SEM, n ≥5. *P <0.05. (B) Decreased B lymphocytes in Zmpste24−/− mice started from 3 months
of age, compared to their wild-type littermates. Data represent mean ± SEM, n = 5. *P <0.05. (C) Representative B cell profile in 5-month-old
Zmpste24−/− mice and control, showing decreased pro-B (B220loCD43+) and pre-B (B220loCD43−) cells. (D) Decreased pro-B and pre-B cells in
5-month-old Zmpste24−/− mice. Data represent mean ± SEM, n = 5. *P <0.05. circ. B, circulating B cells; pre-B cells, B cell precursors; pro-B cells,
progenitor B cells.
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BM microenvironment.
Compromised bone marrow niches in Zmpste24−/− mice
The bone marrow hematopoietic niches provide cytokines
and cell adhesion molecules essential for B cell develop-
ment and survival [10,33]. However the cellular compo-
nents in bone marrow niches are highly complex and still
poorly understood. Recent studies revealed that a subset
of bone marrow stromal cells (BMSCs) expressingvascular cell adhesion molecule-1 (Vcam-1) is essential for
B-lymphopoiesis [34]. Of these reticular Vcam-1+ stromal
cells, roughly 46% express interleukin 7 (IL-7) and around
17% express stromal cell-derived factor-1α (SDF-1α), also
known as chemokine (C-X-C motif) ligand 12 (CXCL12)
or pre-B-cell growth-stimulating factor (PBSF), both of
which are critical for B lymphopoiesis [35]. To investigate
the potential niche defects responsible for the impaired B
lymphopoiesis in Zmpste24−/− mice, BMSCs were cultured
and subjected to cytokine array from 6-month-old
Figure 2 Defective early B lymphopoiesis in Zmpste24−/− mice is cell-extrinsic. (A) Representative plots showing B cell profile (pro- and pre-
B) analyses in recipients with Zmpste24−/− or Zmpste24+/+ donor cells. (B) Detailed B cell profile analyses, including the number of pro-B cells, pre-
B cells and circ. B cells, showed a complete rescue of defective early B cell development in Zmpste24−/− mice. Data represent mean ± SEM, n = 4.
circ. B, circulating B cells; pre-B cells, B cell precursors; pro-B cells, progenitor B cells.
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littermates. With quantification by Image J, 20 out of 96
cytokines showed significant alteration in their expression
level (Figure 3 and [see Figure S1 in Additional file 1]) and
most of them are transcriptional targets of NF-κB
([See Figure S2 in Additional file 2] and online source at
http://www.bu.edu/nf-kb/gene-resources/target-genes/),
indicating a defective NF-κB pathway in Zmpste24−/− mice.
Among those affected, Vcam-1, SDF-1α, tyrosine kinase 3
ligand (Flt3L) and thymic stromal lymphopoietin (TSLP)
are most important for the early B cell development;
Vcam-1, SDF-1α and TSLP are under transcriptional
control of NF-κB signaling [36-38].Defective NF-κB pathway in Zmpste24−/− mice
In canonical NF-κB pathway, the p65/p50 complex is
sequestered in cytoplasm by IκBα/β/ε; upon cytokine
stimulation (for instance, TNFα), IκBα/β/ε is phosphory-
lated by IκB kinase β (IKKβ) and subjected to ubiquitina-
tion and proteasomal degradation, and then the p65/p50
complex is released and enters the nucleus to activate
the relative gene expression [39]. NF-κB pathway activation
is tightly regulated by an IκB-NF-κB negative feedback
loop [40]. In Hoffmann’s model, the nuclear p65/p50
complex activates transcription of IκBα/β/ε, and newly
synthesized IκBα/β/ε inhibited amplification NF-κB
signaling. Analyses of the affected chemokines and
Figure 3 Reduced essential factors required for B lymphopoiesis owing to defective NF-κB signaling in Zmpste24−/− bone marrow
stromal cells. (A) Representative blots showing cytokine expression in wild-type and Zmpste24−/− bone marrow stromal cells (BMSCs).
Corresponding cytokines showed significant difference in (B) were labeled with number. (B) Downregulated cytokines in Zmpste24−/− BMSCs and
most of them (#) are under transcriptional control of NF-κB, especially those required for early B cell development, including Vcam-1, SDF-1α,
Flt3L and TSLP. Data represent mean ± SEM, n = 3. P <0.05, Zmpste24−/− BMSCs versus wild-type. POS, positive control (GAPDH); NEG, negative
control (Blank).
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tool for analysis of protein-protein interaction) suggested
a defect in NF-κB pathway in Zmpste24−/− BMSCs
[See Figure S2 in Additional file 2]. As determined by
nuclear fractionation and western blotting, compared with
wild-type, a downregulation of the nuclear level of p65 in
Zmpste24−/− BMSCs was found (Figure 4, untreated). We
further investigated the dynamic changes of NF-κB signa-
ling in Zmpste24−/− and wild-type BMSCs upon stress. We
transiently stimulated BMSCs with TNFα and examined
the nuclear translocation of p65 protein and cytoplasmiclevel of IκBα/β. As shown in Figure 4, in Zmpste24+/+
BMSCs, the nuclear level of p65 peaked at 10 minutes, then
gradually decreased to the lowest level until 110 minutes
after the stimulation and finally stabilized to normal
level (before treatment) around 160 minutes after the
stimulation. Tightly correlated with the dynamic
changes of p65 level, the lowest level of IκBα/β was
observed around 10 minutes after stimulation and
went to the highest level at 110 minutes and stabilized
around 160 minutes. These results show a beautiful nega-
tive feedback loop of IκB-NF-κB pathway. However, in
Figure 4 Defective NF-κB signaling in Zmpste24−/− bone marrow stromal cells. (A) Representative western blotting results showing that
upon transient TNFα stimulation, NF-κB was defective in activating IκBα/β expression and the following negative feedback in Zmpste24−/− bone
marrow stromal cells (BMSCs). (B) Quantification of p65 and IκBα/β after TNFα treatment in (A) by Image J (see Materials and Methods).
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slightly delayed until 20 minutes and then remained at the
highest level until 160 minutes. In consistent with the
changes of p65, IκBα/β went to its lowest level around 20
minutes after stimulation and remained unchanged until
160 minutes. Since IκBα/β is transcriptionally activated by
NF-κB, these data suggested that although the nuclear
accumulation of p65 was not much affect, the transcrip-
tional activity of NF-κB was significantly compromised in
Zmpste24−/− BMSCs.
Discussion
Bone marrow (BM) hematopoietic niches are essential for
B cell development; they provide cytokines and cell adhe-
sion molecules that are necessary for the survival of the B
cells [10]. About two decades ago, Whitlock and Witte
showed that adherent non-hematopoietic cells have great
potential in supporting B-lymphopoiesis [41]. However
the cellular basis that regulates B-lymphopoiesis is still
poorly understood. Recent studies found that a subset of
bone marrow mesenchymal cells expressing Vcam-1 is
critical for B-lymphopoiesis [34,35]. Schaumann et al.
found that FACS-purified adherent Vcam-1+ stromal cells
share similar surface markers with BMSCs, such as CD13,
CD31, CD90, CD105, etcetera [34], suggesting that
BMSCs, at least the Vcam-1+ subpopulation, might recap-
itulate part of the in vivo B cell niches. In the current
study, we did cytokine array analysis for all BMSCs
regardless of the expression of Vcam-1 because all BM-
derived adherent non-hematopoietic cells have potentials
to support B-lymphopoiesis [41]. We found that a series
of important early B cell factors, including Vcam-1, SDF-
1α and Flt3L, are primarily and significantly affected in
Zmpste24−/− BMSCs. Vcam-1 interacts with very late
antigen integrins (VLA-4), thus mediating the adhesion ofB cell precursors to stromal cells [42,43]. Depleting Vcam-1
in mice results in defective B cell homing to the bone mar-
row [44,45]. SDF-1α belongs to chemokine family and is
mainly recognized by CXC-chemokine receptor 4 (Cxcr4).
Sdf1−/− embryos showed a significantly decreased number
of the earliest stage of B cell precursors in fetal liver [46].
Adoptive transfer experiments showed that Cxcr4−/− fetal
liver cells failed to generate pro-B cells [47]. In chimeric
mice reconstituted with Cxcr4−/− fetal liver cells, the num-
ber of donor-derived pro-B and pre-B cells was significantly
decreased in BM but increased in peripheral blood [48,49].
It has been shown that Vcam-1 is expressed in almost all of
the SDF-1α-expressing cells, whereas only 17% of all the
Vcam-1+ stromal cells are SDF-1α positive and the rest
comprises of a high proportion of IL-7+ cells [34,35]. IL-7 is
the first defined cytokine essential for B cell development
[50]. Research based on both gene targeting and in vitro
culture have shown that IL-7 is necessary for the develop-
ment from pre-pro-B and pro-B stages [10,51]. Although
no significant change of IL-7 expression was observed in
Zmpste24−/− BMSCs (data not shown), we found that Flt3L,
which synergizes with IL-7 to support early B cell develop-
ment [52], is significantly decreased. Therefore defects in
both Vcam-1+SDF-1α+IL-7− and Vcam-1+SDF-1α−IL-7+
bone marrow stromal cells might be responsible for the de-
fective B-lymphopoiesis in Zmpste24−/− mice. In addition
to Vcam-1, SDF-1α and Flt3L, 17 other cytokines also show
significant changes in Zmpste24−/− BMSCs (see Figure 3).
Some of these cytokines, for example, TSLP, are important
for early murine B cell development [53]. However it is still
unclear whether changes in these cytokines represent
defects in Vcam-1− BMSCs that might also be responsible
for the defective B-lymphopoiesis in Zmpste24−/− mice.
Our data are consistent with a previous report showing
extrinsic defects in B and T cell development in Lmna null
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engrafted Lmna null thymus is comparable in the ability to
support T lymphopoiesis and concluded that the defective
T cell development is attributable to the overall unhealthi-
ness of the host animal instead of impaired stromal cells. In
the current study, we employed in vitro expanded BMSCs;
therefore, the defects in various cytokines are independent
of the overall healthiness of examined animals. In this
regard, the effects of lacking lamin A in Lmna null mice
and accumulation of prelamin A in Zmpste24 null mice are
likely different in the regulation of lymphopoietic niches.
Our data are also consistent with a report showing de-
fective NF-κB pathway in Lmna−/− mice [54], where loss
of Lmna compromised IL-1β-stimulated NF-κB-regu-
lated luciferase activity, although the binding of NF-κB
to target sequences was increased. It is worthwhile to
elucidate the underlying molecular mechanism of
defective NF-κB signaling in Zmpste24−/− mice in future
studies. The transcriptional activity of NF-κB can also be
regulated by co-activators, including p300/CBP, PCAF,
p160 proteins (SRC-1/2/3), etcetera, and co-repressors,
such as HDAC1/2/3, SMRT, NcoR, etcetera, which
modulate local chromatin structure and NF-κB signaling.
Given that the chromatin structure is disorganized in
HGPS and normal aging cells [24,55,56], one possibility
is that accumulation of unprocessed prelamin A may
affect local chromatin remodeling and thus impede NF-
κB-mediated transcription activation in Zmpste24−/−
BMSCs. This may also explain the finding that only a set
of targets are affected by defective NF-κB signaling in
Zmpste24−/− BMSCs.
Conclusions
In this study, we found a significant decline in the num-
ber of B cell progenitors in Zmpste24−/− mice. Further
investigation revealed that the defective B-lymphopoiesis
is most likely attributable to decreased NF-κB signaling
in BMSCs, which likely resembles in vivo B cell niches.
Of those 20 affected cytokines in Zmpste24−/− BMSCs,
Vcam-1, SDF-1α, Flt3L and TSLP are among the most
well-studied and are essential for early B lymphopoiesis.
Collectively, our data demonstrate a cell-extrinsic defect
of B cell development in a progeroid mouse model and a
critical role for lamin A in the regulation of NF-κB
signaling and essential cytokines in B-lymphopoiesis. As
progerin accumulates in and contributes to healthy
aging, our data also suggest a mechanistic explanation




PE/Cy5 anti CD45R/B220 (RA3-6B2), R-PE anti CD43
and FITC anti-mouse CD45.2 were sourced fromBioLegend (San Diego, CA, USA). Mouse lineage
panel (anti-CD3ε, anti-CD11b, anti-B220, anti-Ly-6G,
anti-Ly-6C, and anti-TER-119) and anti Biotin microbeads
were purchased from BD Biosciences (San Jose, CA,
USA). Rabbit anti p65, IκB-α, IκB-β and lamin A/C
antibodies were from Santa Cruz (Santa Cruz, CA, USA).
Mouse anti β-actin antibody was from Sigma (St. Louis,
MO, USA).
Animals
Mouse experiments were performed under the regula-
tions and guidelines of the Committee on the Use of
Live Animals in Teaching and Research (CULATR) at
the University of Hong Kong. Zmpste24−/− mice were
described previously [16].
B cell profile analysis and bone marrow transplantation
Bone marrow cells were flushed out into HBSS sup-
plemented with 2% FBS, stained with B cell markers
(PE/Cy5-anti-CD45R/B220 and R-PE-anti-CD43) and
subjected to FACS analysis. For total bone marrow trans-
plantation, 6-month-old B6.SJL/BoyJ mice were irradiated
with 9 Gy and served as recipients. A total of 1×107 bone
marrow nucleated cells from either Zmpste24−/− mice or
wild-type littermates were suspended in 100 μl of HBSS
supplemented with 2% FBS and injected into recipients
via tail vain. FITC-anti-CD45.2 antibody was used to
identify donor-derived lymphocytes.
Bone marrow stromal cell culture and RayBio™ Mouse
Cytokine Antibody Array
BMSCs were cultured as described [57]. Briefly, total
bone marrow cells were flushed out with HBSS buffer
(containing 2% FBS) and taken into culture with 3 ml α-
MEM medium (containing 20% FBS and penicillin-
streptomycin) directly in a 60-mm petri dish. Culture
medium was replaced with fresh α-MEM (containing
20% FBS and no antibiotics) after 24 h, which cleared
most of the unattached cells (including red blood cells)
and cell debris. After 6 days, the P0 culture was trypsi-
nized (with 0.025% trypsin and 0.01% EDTA) for 10
minutes and the detached cells were transferred into a
10-cm petri dish for culture. The cells were then subcul-
tured every 3 to 4 days. After passage four, the BMSC
cultures were subjected to magnetic sorting with BD
mouse lineage panel (anti-CD3ε, anti-CD11b, anti-B220,
anti-Ly-6G, anti-Ly-6C, and anti-TER-119) and anti
Biotin microbeads according to the manufacture’s
instruction. Cells from three different mice were pooled
together for the sake of decrease the background noise
and increasing the robustness of the difference between
mutant and heterozygous mice in the following cytokine
array and protein expression analysis. RayBio™ Mouse
Cytokine Antibody Array III and IV (RayBiotech, USA)
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Zmpste24−/− and Zmpste24+/+ BMSCs. The experiment
was performed according to the instruction of the
manufacturer.
Protein extraction and western blotting
Total cell lysate was prepared by suspending the cells in
five volumes of suspension buffer, and then adding five
volumes of Laemmli buffer and boiling for 5 minutes.
For protein fractionation, cells were suspended in 100 μl
ice-cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl,
1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM
DTT, protease inhibitors). After the addition of 0.1%
Triton X-100, the cell suspension was mixed gently,
incubated on ice for 5 minutes and centrifuged at 1300×g
at 4°C for 4 minutes. The supernatant (S1) was transferred
to a new tube and clarified by high-speed centrifugation
(12000×g, 10 minutes, 4°C). The remaining nuclei
pellet (P1) was washed once with 100 μl buffer A and
then resuspended in 100 μl Laemmli buffer and
boiled for 5 minutes. Western blotting was performed
as described previously [58].
Image quantification and statistics analysis
Photos were processed with Photoshop CSW (Adobe
Systems Incorporated, San Jose, CA, USA) when necessary.
The pixel intensity of western blotting and dot blotting was
measured by Image J gel analysis function [59] and
normalized to housekeeping controls. Student’s t-test
was performed for statistical comparison.
Additional files
Additional file 1: Figure S1. Cytokines that were not affected in
Zmpste24−/− BMSCs.
Additional file 2: Figure S2. Downregulated cytokines in Zmpste24−/−
BMSCs are correlated with NF-κB pathway. (A) Interacting network
among NF-κB pathway and downregulated factors in Zmpste24−/−
BMSCs was predicted by online tool STRING (http://string.embl.de/). (B)
Interacting network among those downregulated factors that are
essential for B cell development and NF-κB signaling, predicted by
STRING. *Significantly downregulated cytokines in Zmpste24−/− BMSCs.
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